Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City

Aim. To evaluate the volume of antithrombotic therapy (ATT) at the prehospital stage in connection with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017.Mate...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
Format: Article
Language:English
Published: Столичная издательская компания 2019-03-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1857
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227676245557248
author A. A. Tuchkov
N. G. Gogolashvili
R. A. Yaskevich
author_facet A. A. Tuchkov
N. G. Gogolashvili
R. A. Yaskevich
author_sort A. A. Tuchkov
collection DOAJ
description Aim. To evaluate the volume of antithrombotic therapy (ATT) at the prehospital stage in connection with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017.Material and methods. The registry included 562 patients with AF at the age of 18 years and older, hospitalized in the cardiology department during 2015-2017. The registry did not include patients with AF and mechanical heart valves, mitral stenosis. The diagnosis of AF was established in accordance with the current recommendations. All patients had an assessment of the risk of thromboembolic complications on the CHA2DS2-VASc scale, the risk of bleeding on the HAS-BLED scale. The incidence of ATT at the prehospital stage was assessed depending on the risk of thromboembolic complications based on patient questioning and analysis of medical records. In addition, an assessment of the dynamics of the frequency of the OAC prescription during 2015-2017 was conducted.Results. The overwhelming majority of patients with AF (96.1%) belonged to the group of high-risk of cardioembolic strokes according to the CHA2DS2-VASc scale and had indications for OAC therapy. The frequency of OAC prescription in patients with AF who were admitted to the cardiology department was 32% at the prehospital stage, of which 19.8% of patients took warfarin and 12.2% – direct OAC. The target level of the international normalized ratio (from 2.0 to 3.0) at the time of hospitalization was observed only in 33.6% of patients taking warfarin. Over the observation period, there was a tendency to increase the frequency of OAC prescription from 30% in 2015 to 38.4% in 2017.Conclusion. Only 32% of patients with AF and high risk of thromboembolic complications received adequate antithrombotic therapy at the prehospital stage. According to the registry the frequency of OAC prescription in patients with AF during 2015-2017 increased by 8.4%. At the same time, there was a significant increase in the frequency of direct OAC prescription.
format Article
id doaj-art-aeb3c0821bd84e57bd7089f24cf1b6e0
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2019-03-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-aeb3c0821bd84e57bd7089f24cf1b6e02025-08-23T10:00:30ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-03-01151434810.20996/1819-6446-2019-15-1-43-481572Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk CityA. A. Tuchkov0N. G. Gogolashvili1R. A. Yaskevich2Scientific Research Institute of Medical Problems of the NorthScientific Research Institute of Medical Problems of the NorthScientific Research Institute of Medical Problems of the NorthAim. To evaluate the volume of antithrombotic therapy (ATT) at the prehospital stage in connection with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017.Material and methods. The registry included 562 patients with AF at the age of 18 years and older, hospitalized in the cardiology department during 2015-2017. The registry did not include patients with AF and mechanical heart valves, mitral stenosis. The diagnosis of AF was established in accordance with the current recommendations. All patients had an assessment of the risk of thromboembolic complications on the CHA2DS2-VASc scale, the risk of bleeding on the HAS-BLED scale. The incidence of ATT at the prehospital stage was assessed depending on the risk of thromboembolic complications based on patient questioning and analysis of medical records. In addition, an assessment of the dynamics of the frequency of the OAC prescription during 2015-2017 was conducted.Results. The overwhelming majority of patients with AF (96.1%) belonged to the group of high-risk of cardioembolic strokes according to the CHA2DS2-VASc scale and had indications for OAC therapy. The frequency of OAC prescription in patients with AF who were admitted to the cardiology department was 32% at the prehospital stage, of which 19.8% of patients took warfarin and 12.2% – direct OAC. The target level of the international normalized ratio (from 2.0 to 3.0) at the time of hospitalization was observed only in 33.6% of patients taking warfarin. Over the observation period, there was a tendency to increase the frequency of OAC prescription from 30% in 2015 to 38.4% in 2017.Conclusion. Only 32% of patients with AF and high risk of thromboembolic complications received adequate antithrombotic therapy at the prehospital stage. According to the registry the frequency of OAC prescription in patients with AF during 2015-2017 increased by 8.4%. At the same time, there was a significant increase in the frequency of direct OAC prescription.https://www.rpcardio.online/jour/article/view/1857atrial fibrillationoral anticoagulantsantithrombotic therapynew oral anticoagulantswarfarinstrokebleeding
spellingShingle A. A. Tuchkov
N. G. Gogolashvili
R. A. Yaskevich
Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
Рациональная фармакотерапия в кардиологии
atrial fibrillation
oral anticoagulants
antithrombotic therapy
new oral anticoagulants
warfarin
stroke
bleeding
title Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
title_full Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
title_fullStr Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
title_full_unstemmed Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
title_short Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
title_sort assessment of antithrombotic therapy in patients with atrial fibrillation for 2015 2017 according to the registry of the clinic of the scientific research institute of medical problems of the north of krasnoyarsk city
topic atrial fibrillation
oral anticoagulants
antithrombotic therapy
new oral anticoagulants
warfarin
stroke
bleeding
url https://www.rpcardio.online/jour/article/view/1857
work_keys_str_mv AT aatuchkov assessmentofantithrombotictherapyinpatientswithatrialfibrillationfor20152017accordingtotheregistryoftheclinicofthescientificresearchinstituteofmedicalproblemsofthenorthofkrasnoyarskcity
AT nggogolashvili assessmentofantithrombotictherapyinpatientswithatrialfibrillationfor20152017accordingtotheregistryoftheclinicofthescientificresearchinstituteofmedicalproblemsofthenorthofkrasnoyarskcity
AT rayaskevich assessmentofantithrombotictherapyinpatientswithatrialfibrillationfor20152017accordingtotheregistryoftheclinicofthescientificresearchinstituteofmedicalproblemsofthenorthofkrasnoyarskcity